Dallah profit jumps 30% to SAR 155.6M in Q1 2025

11/05/2025 Argaam Exclusive

Content Summary:

Loading data...

Comments Analysis:

Positive: 0%
Neutral: 0%
Negative: 0%
Comments Summary:Loading data...
Please note that this news summary has been generated using artificial intelligence. It is recommended to review the original sources for complete details and to verify the accuracy of the information.

Dallah Healthcare Co.’s Q1 2025 net profit jumped 30% to SAR 155.6 million from SAR 119.3 million in Q1 2024.



Current Quarter Comparison (M)

Compared With The
Item Q1 2024 Q1 2025 Change‬
Revenues 784.06 832.75 6.2 %
Gross Income 293.36 297.61 1.4 %
Operating Income 149.24 177.89 19.2 %
Net Income 119.30 155.56 30.4 %
Average Shares 97.68 97.68 -
Earnings Per Share before unusual items (Riyals) 1.22 1.07 (12.4 %)
EPS (Riyals) 1.22 1.59 30.4 %

The profit increase is driven by a 6.2% year-on-year (YoY) rise in revenue to SAR 833 million. This increase was realized despite the current quarter being impacted by the seasonality associated with the month of Ramadan and Eid Al-Fitr. This was driven by increased operational capacity as a result of the group's strategic expansions, both in existing and acquired medical facilities, which contributed to the continued growth in the number of patients for the group's hospitals.

 

The acquisition of Al-Salam Medical Services Co. (owner of Dallah Al-Khobar Hospital), and Al-Ahsa Medical Services Co. (owner of Dallah Al-Ahsa Hospital), had a positive impact on revenue growth.

 

In addition, the company's 33.33% stake in a real estate fund through an in-kind contribution of lands resulted in non-recurring gains of SAR 51 million. The fund raised SAR 613 million in capital and aims to develop a mixed-use project comprising commercial, office, hospitality, and healthcare space in Al Nakheel district on King Fahd Road in Riyadh.

On a sequential basis, the net earnings grew by 36.6% from SAR 113.9 million in Q4 2024.

 

Shareholders’ equity, excluding minority interest, reached SAR 4.06 billion as of March 31, 2025, up from SAR 3.32 billion a year earlier.

 

 

 

View More Financial Results

 

View other reports

Share Price

Dallah Healthcare Co.
120.00
1.20 1.01 %

Dallah Healthcare Co. (DALLAH HEALTH)

More


Financial Ratios
Current
Market Cap (M Riyal) 12,189.00
Enterprise Value (EV) (M) 14,197.99
Shares Outstanding ((M)) 101.58
EPS ( Riyal) (TTM) 5.20
Book Value (BV) ( Riyal) 39.98
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 26.70
P/E (TTM) 24.02
Price/book 3.00
Return on Average Assets (%) (TTM) 7.9
Return on Average Equity (%) (TTM) 13.7
more

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2025, Argaam Investment, All Rights Reserved
Call Request